Dhampur Bio Organics: ₹305 Cr Unit Sale, ₹1.50 Dividend, New Acquisition Approved

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Dhampur Bio Organics: ₹305 Cr Unit Sale, ₹1.50 Dividend, New Acquisition Approved
Overview

Dhampur Bio Organics announced its FY26 results, recommending a ₹1.50 dividend. The company will sell its Meerganj unit for ₹305 crore and acquire Sonitron Chemicals to enter new markets. An income tax search was conducted but no material adjustments are expected currently.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Dhampur Bio Organics Approves ₹305 Cr Divestment, Recommends Dividend

Dhampur Bio Organics Ltd. reported its audited financial results for the fiscal year ended March 31, 2026. The company announced a recommended final dividend of ₹1.50 per equity share and significant corporate actions including the sale of its Meerganj unit for ₹305 crore and the acquisition of Sonitron Chemicals Private Limited.

Reader Takeaway: Divestment of ₹305 crore unit for strategic focus; tax search adds uncertainty.

What just happened

Dhampur Bio Organics announced its audited financial results for the fiscal year ending March 31, 2026. Key highlights include a recommended final dividend of ₹1.50 per equity share. The company also confirmed the sale of its sugar manufacturing unit in Meerganj, Bareilly, for ₹305 crore and the approval to acquire Sonitron Chemicals Private Limited.

Why this matters

These decisions signal a strategic shift for Dhampur Bio Organics, focusing on core strengths and expanding into new agri-product segments. The sale of the Meerganj unit generates significant capital, while the acquisition aims to diversify revenue streams. The dividend provides a direct return to shareholders.

The backstory

Dhampur Bio Organics has been involved in sugar manufacturing and related bio-products. The company operates in the seasonal sugar industry. Recently, the company underwent an Income Tax Department search from October 29, 2025, to November 04, 2025.

What changes now

With the sale of the Meerganj unit, the company will streamline its operations. The acquisition of Sonitron Chemicals is expected to open new market segments in agri and allied products. The recommended dividend is subject to shareholder approval and record date.

Risks to watch

The primary risk highlighted is the ongoing uncertainty surrounding the Income Tax Department search. While management has stated no material adjustments are expected currently, the final outcome could potentially impact the company. The sugar industry's seasonal nature also affects financial performance.

Peer comparison

Companies in the sugar and agri-business sector often undergo such strategic divestments or acquisitions to optimize operations and expand market reach. Specific peer financial performance varies based on individual product portfolios and operational efficiencies.

Context metrics (time-bound)

  • Standalone Revenue (FY26): ₹3,106.17 crore
  • Consolidated Revenue (FY26): ₹3,133.41 crore
  • Standalone Net Profit (FY26): ₹24.97 crore
  • Consolidated Net Profit (FY26): ₹25.18 crore
  • Divestment Consideration: ₹305 crore
  • Recommended Dividend: ₹1.50 per share
  • Income Tax Search: October 29, 2025 - November 04, 2025
  • Dividend Record Date: July 17, 2026

What to track next

Investors should monitor the effective execution of the Sonitron Chemicals acquisition and the deployment of capital from the Meerganj unit sale. The outcome of the Income Tax Department search and any potential impact on future financial reporting will also be crucial.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.